The MED13L Haploinsufficiency Syndrome Associated with De Novo Nonsense Variant (P.GLN1981*)
暂无分享,去创建一个
R. Płoski | W. Wiszniewski | M. Rydzanicz | J. Kosińska | M. Dawidziuk | M. Gos | M. Bekiesińska-Figatowska | P. Stawiński | J. Bernaciak | A. Kutkowska-Kaźmierczak | K. Szczałuba | J. Bal | P. Gawliński | P. Własienko | Magdalena Bartnik-Głaska | Olga Malinowska Kordowska | Sylwia Olimpia Rzońca-Niewczas | Paweł Gawliński
[1] M. Larsen,et al. Is MED13L-related intellectual disability a recognizable syndrome? , 2019, European journal of medical genetics.
[2] A. Afenjar,et al. MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype , 2018, neurogenetics.
[3] R. Schiffmann,et al. Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation. , 2017, European journal of medical genetics.
[4] Joan,et al. Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.
[5] Steven P. Angus,et al. Rede fi ning the MED 13 L syndrome , 2015 .
[6] R. Płoski,et al. Does p.Q247X in TRIM63 Cause Human Hypertrophic Cardiomyopathy? , 2014, Circulation research.
[7] G. Houge,et al. Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability , 2013, European Journal of Human Genetics.
[8] J. Goodship,et al. Missense Mutations and Gene Interruption in PROSIT240, a Novel TRAP240-Like Gene, in Patients With Congenital Heart Defect (Transposition of the Great Arteries) , 2003, Circulation.